Innovative Eyewear Inc. logo

Innovative Eyewear Inc.(LUCY)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.78
11/16/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for LUCY

11/16/2026: LUCY (1-star) is currently NOT-A-BUY. Pass it for now.

Innovative Eyewear Inc. is a micro-cap smart eyewear developer and stock specializing in Bluetooth-enabled audio glasses and safety frames sold under proprietary and major licensed brands like Reebok and Nautica. The company's primary business strength is its consistent double-digit top-line revenue growth and successful expansion into major wholesale and big-box retail channels. Its key investment opportunity lies in scaling its high-demand Lucyd Armor safety line and international distribution network. However, primary risks include ongoing net losses, negative cash flows, high price volatility, and intense competition from well-funded technology giants. The stock best suits high-risk growth investors willing to monitor cash burn and dilution developments closely.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fit while signal remains positiveThe company delivers rapid double-digit top-line revenue expansion and aggressive distribution scaling in the emerging smart eyewear market.
Momentum investorStrong fit while signal remains positiveLow float and frequent product launch catalysts frequently trigger sharp trading volume surges and high short-term price momentum.
Value investorWeak fitThe stock lacks positive earnings, positive free cash flow, or established book-value safety margins at its current micro-cap stage.
Dividend investorWeak fitThe company pays zero dividends, retaining all capital to fund ongoing operational scaling and market expansion.
Low-risk investorWeak fitHigh equity volatility, micro-cap liquidity profiles, and ongoing net losses expose investors to significant downside risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe low share price and small public float cause outsized daily percentage swings and high market beta.
Valuation riskMedium / highPricing depends heavily on forward revenue growth assumptions rather than current earnings or profitability.
Competition risk (consumer tech giants and audio wearable competitors)HighWell-capitalized technology enterprises pose a constant threat of overshadowing boutique wearable brands.
Business qualityMediumWhile brand partnerships add legitimacy, the business model is still unproven at scale and lacks operating profitability.
Dividend incomeLow / noneIncome-seeking investors receive no dividend yield or cash distributions.
Execution riskHighManagement must successfully scale inventory, manage retail channels, and control cash burn to survive.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.81M USD
Price to earnings Ratio -
1Y Target Price 3
Price to earnings Ratio -
1Y Target Price 3
Volume (30-day avg) 137.0K shares
Beta 2.74
52 Weeks Range 0.65 - 2.00
Updated Date 11/16/2026
52 Weeks Range 0.65 - 2.00
Updated Date 11/16/2026
Dividends yield (FY) -
Basic EPS (TTM) -1.17

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
63.9%
Active BUY / eligible
69 / 108
30-Day BUY Count Change
+31
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Instruments & Supplies

BUY participation
40.0%
Active BUY / eligible
2 / 5
30-Day BUY Count Change
0

Eligible universe: 5 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -40%
Avg. Invested days 8
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/16/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
LUCY receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
LUCY has moderate overall fundamentals (3 stars), with soft financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, moderate earnings growth (+2.3%) and strong revenue growth (+62.6%) are partially offset by weak cash generation (FCF margin -282.7%), weak profitability (net margin -285.2%).

Financial Health Rating

★★★★★
LUCY's financial health is soft, with the relatively strongest area being moderate liquidity, including working-capital and asset support (WC/assets 82.7%). Operating efficiency is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is LUCY's strongest growth driver at +62.6% FY2025 versus FY2024 (strong, 5 stars). By comparison, while earnings growth (+2.3%, moderate) and free-cash-flow growth (-7.4%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 11.2% and approximately 89.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 17.03% supports management-shareholder alignment.

Top 5 Institutional Investors

Cetera Investment Advisers 6.63%
XTX Topco Ltd 0.47%
Citadel Advisors Llc 0.34%
KeyBank National Association 0.23%
Geode Capital Management, LLC 0.21%

Unit Economics (Per $1K Revenue)

★★★★★
LUCY generates approximately $213 of gross profit, $-3,192 of operating income, and $-2,827 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
LUCY has a liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Smart Eyewear ProductsDirect sales of Lucyd Lyte, Lucyd Armor, and co-branded frames via e-commerce and retail channels.This is the primary engine driving top-line revenue growth.
Wholesale & International DistributionBulk sales to optical shops, safety distributors, and global partners like Directed Electronics in Australia and New Zealand.Wholesale expansion provides scalable volume beyond direct-to-consumer web sales.
Licensed Brand CollaborationsSmart glasses marketed under licensed household names including Reebok, Nautica, and Eddie Bauer.Brand licensing helps lower customer acquisition friction and opens mainstream retail doors.

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2.55M
Price to Sales(TTM) 1.82
Enterprise Value 2.55M
Price to Sales(TTM) 1.82
Enterprise Value to Revenue 0.68
Enterprise Value to EBITDA -0.04
Shares Outstanding 8.71M
Shares Floating 7.76M
Shares Outstanding 8.71M
Shares Floating 7.76M
Percent Insiders 17.03
Percent Institutions 11.23

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.